Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 7631804, 7 pages
http://dx.doi.org/10.1155/2016/7631804
Research Article

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome

1Department of Pharmacotherapy & Outcomes Science, School of Pharmacy, Virginia Commonwealth University, P.O. Box 980533, Richmond, VA 23298-0533, USA
2Virginia Commonwealth University Institute for Women’s Health, P.O. Box 980319, Richmond, VA 23298-0319, USA
3Bionutrition Service, Center for Clinical and Translational Research, Virginia Commonwealth University, P.O. Box 980155, Richmond, VA 23298-0155, USA
4Carilion Clinic Obstetrics & Gynecology, 102 Highland Ave, Suite 455, Roanoke, VA 24013, USA
5Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, P.O. Box 980111, Richmond, VA 23298-0111, USA

Received 22 June 2016; Accepted 22 August 2016

Academic Editor: Franco Veglio

Copyright © 2016 Kai I. Cheang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Knochenhauer, T. J. Key, M. Kahsar-Miller, W. Waggoner, L. R. Boots, and R. Azziz, “Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 9, pp. 3078–3082, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Nestler, D. J. Jakubowicz, A. F. de Vargas, C. Brik, N. Quintero, and F. Medina, “Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 6, pp. 2001–2005, 1998. View at Publisher · View at Google Scholar
  3. A. Dunaif, J. Mandeli, H. Fluhr, and A. Dobrjansky, “The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome,” Obstetrical and Gynecological Survey, vol. 43, no. 11, pp. 688–690, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Romero and J. Larner, “Insulin mediators and the mechanism of insulin action,” Advances in Pharmacology, vol. 24, pp. 21–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Asplin, G. Galasko, and J. Larner, “Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 5924–5928, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-P. Baillargeon, E. Diamanti-Kandarakis, R. E. Ostlund Jr., T. Apridonidze, M. J. Iuorno, and J. E. Nestler, “Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome,” Diabetes Care, vol. 29, no. 2, pp. 300–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-P. Baillargeon, M. J. Iuorno, D. J. Jakubowicz, T. Apridonidze, N. He, and J. E. Nestler, “Metformin therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 1, pp. 242–249, 2004. View at Publisher · View at Google Scholar
  8. J. E. Nestler, D. J. Jakubowicz, P. Reamer, R. D. Gunn, and G. Allan, “Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome,” The New England Journal of Medicine, vol. 340, no. 17, pp. 1314–1320, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Iuorno, D. J. Jakubowicz, J.-P. Baillargeon et al., “Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome,” Endocrine Practice, vol. 8, no. 6, pp. 417–423, 2002. View at Publisher · View at Google Scholar
  10. A. S. Laganà, L. Barbaro, and A. Pizzo, “Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol,” Archives of Gynecology and Obstetrics, vol. 291, no. 5, pp. 1181–1186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Gupta, D. Jakubowicz, and J. E. Nestler, “Pioglitazone therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome,” Metabolic Syndrome and Related Disorders, 2016. View at Publisher · View at Google Scholar
  12. J.-P. Baillargeon, M. J. Iuorno, T. Apridonidze, and J. E. Nestler, “Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome,” Metabolic Syndrome and Related Disorders, vol. 8, no. 2, pp. 127–136, 2010. View at Publisher · View at Google Scholar
  13. R. Azziz, E. Carmina, D. Dewailly et al., “Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4237–4245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. The Obesity Society, “Guidelines for management of the obese and overweight,” Obesity, vol. 6, no. 2, pp. 51S–179S, 1998. View at Publisher · View at Google Scholar
  15. N. G. Boulé, S. J. Weisnagel, T. A. Lakka et al., “Effects of exercise training on glucose homeostasis,” Diabetes Care, vol. 28, no. 1, pp. 108–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Södergard, T. Bäckström, V. Shanbhag, and H. Carstensen, “Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature,” Journal of Steroid Biochemistry, vol. 16, no. 6, pp. 801–810, 1982. View at Publisher · View at Google Scholar
  17. P. N. Shashkin, E. F. Shashkina, E. Fernqvist-Forbes, Y.-P. Zhou, V. Grill, and A. Katz, “Insulin mediators in man: effects of glucose ingestion and insulin resistance,” Diabetologia, vol. 40, no. 5, pp. 557–563, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999. View at Publisher · View at Google Scholar
  19. M. L. Dansinger, J. A. Gleason, J. L. Griffith, H. P. Selker, and E. J. Schaefer, “Comparison of the atkins, ornish, weight watchers, and zone diets for weight loss and heart disease risk reduction: a randomized trial,” The Journal of the American Medical Association, vol. 293, no. 1, pp. 43–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. I. Cheang, J.-P. Baillargeon, P. A. Essah et al., “Insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome,” Metabolism: Clinical and Experimental, vol. 57, no. 10, pp. 1390–1397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Moran, S. K. Hutchison, R. J. Norman, and H. J. Teede, “Lifestyle changes in women with polycystic ovary syndrome,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD007506, 2011. View at Publisher · View at Google Scholar
  22. R. Pasquali, A. Gambineri, C. Cavazza et al., “Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome,” European Journal of Endocrinology, vol. 164, no. 1, pp. 53–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. J. Moran, M. Noakes, P. M. Clifton, L. Tomlinson, and R. J. Norman, “Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 2, pp. 812–819, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Sigal, M. El-Hashimy, B. C. Martin, J. S. Soeldner, A. S. Krolewski, and J. H. Warram, “Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study,” Diabetes, vol. 46, no. 6, pp. 1025–1029, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Evangelou, T. Tzotzas, G. Christou, M. S. Elisaf, and D. N. Kiortsis, “Does the presence of metabolic syndome influence weight loss in obese and overweight women?” Metabolic Syndrome and Related Disorders, vol. 8, no. 2, pp. 173–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. McLaughlin, F. Abbasi, M. Carantoni, P. Schaaf, and G. Reaven, “Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 2, pp. 578–581, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. K. M. Hoeger, L. Kochman, N. Wixom, K. Craig, R. K. Miller, and D. S. Guzick, “A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study,” Fertility and Sterility, vol. 82, no. 2, pp. 421–429, 2004. View at Publisher · View at Google Scholar · View at Scopus